Cargando. Por Favor Espere...
Cargando. Por Favor Espere...
The myPrenatal Test safely and noninvasively screens for the most common chromosomal aneuploidies as early as 10 weeks gestation using a single maternal blood draw, offering the lowest test failure rate in the industry. The myPrenatal Test uses sequencing technology to provide accurate information for pregnant women regardless of age or risk.
»» Safe — Routine, non-invasive blood draw, from the mother, requires just one small blood sample.
»» Accurate — Directly analyzes cell-free fetal and maternal DNA with a proprietary algorithm; with the lowest test failure rate in the industry (0.1%).
»» Easy — Test as early as 10 weeks (gestational age). No limits regarding ethnicity, BMI, ART (including IVF) or egg donor cases.
»» Fast — Results reported to provider 3 to 5 days after sample receipt at lab. Time to report may vary based on laboratory.
Noninvasive prenatal testing (NIPT) based on cell-free DNA analysis from maternal blood is a screening test; it is not diagnostic. False positive and false negative results do occur. Test results must not be used as the sole basis for diagnosis.
Further confirmatory testing is necessary prior to making any irreversible pregnancy decision. A negative result does not eliminate the possibility that the pregnancy has a chromosomal or subchromosomal abnormality. This test does not screen for polyploidy (eg, triploidy), birth defects such as open neural tube defects, single gene disorders, or other conditions, such as autism. There is a small possibility that the test results might not reflect the chromosomal status of the fetus, but may instead reflect chromosomal changes in the placenta (confined placental mosaicism, CPM) or the mother that may or may not have clinical significance.
myPrenatal is a non-invasive screening test that provides reliable answers about the health of your developing fetus. Our simple test screens for the three most common chromosomal abnormalities:
»» DOWN SYNDROME (TRISOMY 21) is associated with developmental and intellectual delays, ranging from mild to severe
»» TRISOMY 18 is a condition that causes severe developmental delays and birth defects
»» TRISOMY 13 is a condition that causes severe intellectual disability and physical defects
»» Fetal sex
»» Sex chromosome aneuploidies
»» Microdeletion syndromes
»» All chromosome analysis (all trisomies including 9 and 16)
»» Test can be taken as early as week ten of pregnancy
A report with your results is provided to you and your physician with 2 possible outcomes:
»» Aneuploidy not detected (negative) — No extra or missing chromosomes were detected
»» Aneuploidy detected (positive) — Extra or missing chromosomes were detected.* Results should be confirmed by a diagnostic procedure if a more definitive diagnosis is desired.
* Positive Predictive Value (PPV) is included in the report. PPV is the probability that the result is a true positive and the fetus is affected.
Order test
Talk to your physician or genetic counselor about ordering a myPrenatal test.
Provide sample
Have the mother’s blood drawn. A sample size of 7-10ml is all that is needed.
Process sample
We’ll process your sample at one of our CLIA-certified labs.
Receive report
Results are delivered 3 to 5 days after receipt at our lab. Talk to your physician or genetic counselor about your results, especially when there is a positive finding.
»» myPrenatal uses whole-genome sequencing (WGS) to screen for common fetal aneuploidies and provide accurate information for pregnant women regardless of age or risk.
»» A technology called “massively parallel sequencing” is used to count the amount of DNA from each test chromosome and/or from specific regions of chromosomes. The laboratory then uses an analysis method to determine if each of the conditions you have elected to test for is likely to be present or absent.
»» myPrenatal, based on cell-free DNA analysis from maternal blood, is a screening test; it is not diagnostic. False positive and false negative results do occur, although this method has demonstrated excellent detection rates and very low false positive rates. Test results must not be used as the sole basis for diagnosis.
»» The test is performed in a CLIA-certified laboratory following LDT regulations.
